Fig. 2From: Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomesThe 94-SNP risk score repartition among the breast cancer patient population: normal distribution. SNP single nucleotide polymorphismBack to article page